The Food and Drugs Authority (FDA) has announced the appointment of Professor Kwabena Frimpong-Manso Opuni as its new Acting Chief Executive Officer (CEO), effective Monday, July 14, 2025.
Prof. Opuni takes over from Dr. Delese Mimi Darko, who has served as CEO since 2017. Dr. Darko was recently appointed as the Director General of the Africa Medicines Agency (AMA), marking a significant milestone in her distinguished career in public health leadership.
Prior to his new role, Prof. Opuni served as the Board Chairman of the FDA, bringing with him extensive experience in public health policy, regulatory oversight, and institutional governance.
In a statement, the FDA extended its warmest congratulations to Prof. Opuni and expressed confidence in his ability to lead the Authority in fulfilling its mandate of safeguarding public health and safety.
Prof. Opuni’s appointment comes at a time when the Authority is focused on strengthening regulatory systems, enhancing consumer protection, and ensuring the safety and efficacy of food, drugs, and other regulated products in Ghana.
